DG Preventive Cardio
Preventive genetic study to determine the risk of developing cardiovascular disease
Our preventive test in cardiology
DG Preventive Cardio is a preventive genetic test that analyzes 124 genes associated with 34 inherited cardiovascular diseases.
All the genes included in this test have been selected on the basis of clinical and scientific criteria based on the recommendations of the ACMG(American College of Medical Genetics and Genomics) and other scientific societies, such as the American Heart Association.
Its realization provides the following advantages:
- It reduces uncertainty and anxiety about the risk of inherited cardiovascular disease.
- It provides valuable information for the entire family, even for members who have not been tested.
- It allows for appropriate follow-up for each family member based on the results obtained.
- EDTA blood (1x 5 ml)
- Saliva (specific Isohelix kit)
- Buccal exudate (2x sterile isopes)
- Isolated DNA (>30 ng/μl in >100 μl)
Remember to label each sample with the patient's first and last name or with the identifier used on the request form.
Why is it important to do so?
Cardiovascular diseases are the leading cause of death worldwide and up to 25% of sudden cardiac deaths are due to genetic abnormalities in genes responsible for the structure of the heart muscle or heart rhythm.
DG Preventive Cardio can help to identify the existence of mutations in genes related to these pathologies, allowing the implementation of appropriate preventive measures and the follow-up of these patients by medical specialists.
Source: Eur Heart J. 2022.
Who is our DG Preventive Cardio study aimed at?
- People with a family history of hereditary cardiovascular disease.
- Healthy people who are concerned about their own health care and that of their family members.
- Amateur or professional athletes who want to know their risk of cardiac pathology.
We offer the possibility of performing the genetic study from a saliva sample. For this purpose, we provide our clients with saliva collection kits, so that the patient can collect the sample comfortably at home. Each kit contains a saliva collector, collection instructions, a request form and an informed consent form.
Technical characteristics
- Whole Exome Sequencing
- SureSelect Human All Exon V8 Library
- Illumina® technology NovaSeq 6000 platform
- Average coverage 100 x - 150 x
- Bioinformatics analysis using our software Genome One
- Classification of variants according to ACMG criteria
- Analysis of SNVs, Indels and CNVs
- Samples: EDTA blood, saliva and buccal exudate.
- Delivery time: 35-45 days
Other options available
DG Preventive Cancer
DG Preventive Cancer is a preventive genetic test that studies 86 actionable genes related to different types of hereditary cancer.
DG Preventive Essential
DG Preventive Essential is a test that analyzes the 81 actionable genes recommended by the ACMG for study related to 37 high-incidence diseases, most of them cardiovascular diseases and cancer.
DG Preventive Premium
DG Preventive Premium is a preventive genetic test that analyzes 344 genes related to the risk of developing hereditary cardiovascular diseases, hereditary cancer and autosomal recessive or X-linked diseases.
Our DG Preventive report
- All DG Preventive reports are written in a simple way so that they can be easily understood by the patient.
- Pathogenic and Probably Pathogenic variants are reported according to the ACMG classification.
- The possible outcomes and the implication of each of them are explained in detail.
- Recommendations for the patient and family members are included.
- Information on the genes analyzed and the diseases studied is included.
DG Preventive Cardio
Preventive genetic study to determine the risk of developing cardiovascular disease
Our preventive test in cardiology
DG Preventive Cardio is a preventive genetic test that analyzes 124 genes associated with 34 inherited cardiovascular diseases.
All the genes included in this test have been selected on the basis of clinical and scientific criteria based on the recommendations of the ACMG(American College of Medical Genetics and Genomics) and other scientific societies, such as the American Heart Association.
Its realization provides the following advantages:
- It reduces uncertainty and anxiety about the risk of inherited cardiovascular disease.
- It provides valuable information for the entire family, even for members who have not been tested.
- It allows for appropriate follow-up for each family member based on the results obtained.
Who is our DG Preventive Cardio study aimed at?
- People with a family history of hereditary cardiovascular disease.
- Healthy people who are concerned about their own health care and that of their family members.
- Amateur or professional athletes who want to know their risk of cardiac pathology.
We provide our customers with saliva collection kits, so that the patient can collect the sample with total comfort at home.
Features
- Whole Exome Sequencing
- SureSelect Human All Exon V8 Library
- Illumina® technology NovaSeq 6000 platform
- Medium coverage 100-150x
- Bioinformatics analysis using our software Genome One
- Classification of variants according to ACMG criteria
- Analysis of SNVs, Indels and CNVs
- Samples: EDTA blood, saliva and buccal exudate.
- Delivery time: 35-45 days
Other options available
DG Preventive Cancer
DG Preventive Cancer is a preventive genetic test that studies 86 actionable genes related to different types of hereditary cancer.
DG Preventive Essential
DG Preventive Essential is a test that analyzes the 81 actionable genes recommended by the ACMG for study related to 37 high-incidence diseases, most of them cardiovascular diseases and cancer.
DG Preventive Premium
DG Preventive Premium is a preventive genetic test that analyzes 344 genes related to the risk of developing hereditary cardiovascular diseases, hereditary cancer and autosomal recessive or X-linked diseases.
Our DG Preventive genetic report
- All DG Preventive reports are written in a simple way so that they can be easily understood by the patient.
- Pathogenic and Probably Pathogenic variants are reported according to the ACMG classification.
- The possible outcomes and the implication of each of them are explained in detail.
- Recommendations for the patient and family members are included.
- Information on the genes analyzed and the diseases studied is included.
DG Preventive Cardio
Preventive genetic study to determine the risk of developing cardiovascular disease
Our preventive test in cardiology
DG Preventive Cardio is a preventive genetic test that analyzes 124 genes associated with 34 inherited cardiovascular diseases.
All the genes included in this test have been selected on the basis of clinical and scientific criteria based on the recommendations of the ACMG(American College of Medical Genetics and Genomics) and other scientific societies, such as the American Heart Association.
Its realization provides the following advantages:
- It reduces uncertainty and anxiety about the risk of inherited cardiovascular disease.
- It provides valuable information for the entire family, even for members who have not been tested.
- It allows for appropriate follow-up for each family member based on the results obtained.
Features
- Whole Exome Sequencing
- SureSelect Human All Exon V8 Library
- Illumina® technology NovaSeq 6000 platform
- Medium coverage 100-150x
- Bioinformatics analysis using our software Genome One
- Classification of variants according to ACMG criteria
- Analysis of SNVs, Indels and CNVs
- Samples: EDTA blood, saliva and buccal exudate.
- Delivery time: 35-45 days
DG Preventive Report
- All DG Preventive reports are written in a simple way so that they can be easily understood by the patient.
- Pathogenic and Probably Pathogenic variants are reported according to the ACMG classification.
- The possible outcomes and the implication of each of them are explained in detail.
- Recommendations for the patient and family members are included.
- Information on the genes analyzed and the diseases studied is included.